(Q73740070)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10793019%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Atherogenic lipoprotein phenotype in end-stage renal failure: origin and extent of small dense low-density lipoprotein formation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10793019%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

C J Deighan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10793019%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

M J Caslake

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10793019%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

M McConnell

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10793019%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

J M Boulton-Jones

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10793019%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

C J Packard

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10793019%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 May 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10793019%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Kidney Diseases

6 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10793019%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10793019%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10793019%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

852-862

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10793019%20AND%20SRC:MED&resulttype=core&format=json

Lipoprotein metabolism and renal failure

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970255-1

7 January 2021

Lipid abnormalities in end stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970255-1

7 January 2021

Evidence that reduced lipoprotein lipase activity is not a primary pathogenetic factor for hypertriglyceridemia in renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970255-1

7 January 2021

Hyperapobetalipoproteinemia: the major dyslipoproteinemia in patients with chronic renal failure treated with chronic ambulatory peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970255-1

7 January 2021

Heterogeneity of plasma low-density lipoproteins and atherosclerosis risk

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970255-1

7 January 2021

A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970255-1

7 January 2021

Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970255-1

7 January 2021

Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970255-1

7 January 2021

Lipoprotein heterogeneity and apolipoprotein B metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970255-1

7 January 2021

Incidence and risk factors of atherosclerotic cardiovascular accidents in predialysis chronic renal failure patients: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970255-1

7 January 2021

Low-density lipoprotein particle size distribution in end-stage renal disease treated with hemodialysis or peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970255-1

7 January 2021

Low-density lipoprotein subfraction profiles in chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970255-1

7 January 2021

Rapid isolation of low density lipoprotein (LDL) subfractions from plasma by density gradient ultracentrifugation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970255-1

7 January 2021

Plasma cholesterol metabolism in end-stage renal disease. Difference between treatment by hemodialysis or peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970255-1

7 January 2021

Increased activity of plasma cholesteryl ester transfer protein in children with end-stage renal disease receiving continuous ambulatory peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970255-1

7 January 2021

Relations Between Plasma Lipids and Postheparin Plasma Lipases and VLDL and LDL Subfraction Patterns in Normolipemic Men and Women

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970255-1

7 January 2021

Effect of insulin therapy on metabolic fate of apolipoprotein B-containing lipoproteins in NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970255-1

7 January 2021

Metabolism of apolipoprotein B-containing lipoproteins in subjects with nephrotic-range proteinuria

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970255-1

7 January 2021

Kinetics of peritoneal protein loss during CAPD: I. Different characteristics for low and high molecular weight proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970255-1

7 January 2021

Controlling the epidemic of cardiovascular disease in chronic renal disease: where do we start?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970255-1

7 January 2021

Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970255-1

7 January 2021

Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970255-1

7 January 2021

Influence of plasma lipid and LDL-subfraction profile on the interaction between low density lipoprotein with human arterial wall proteoglycans

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970255-1

7 January 2021

Should hyperlipidaemia in dialysis patients be treated?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970255-1

7 January 2021

10.1016/S0272-6386(00)70255-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10793019%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference